Rosetta Omics
1 known investors
Find your way into Rosetta Omics
1,105 people in our graph share verified history with the Rosetta Omics team — schools, employers, funds. One of them is your warm intro.
Remy Martinunlockedknows Matteo Oldani · together at KPMG Advisory (overlapped)
×2knows the team · via KPMG Advisory
knows the team · via The University of Texas at Austin
×2knows the team · via SDA Bocconi
knows the team · via Università Cattolica del Sacro Cuore
×2knows the team · via Bayer
Rosetta Omics is a deeptech healthcare startup combining spatial multiomics profiling and AI to advance precision medicine in oncology. It develops technology for cancer diagnostics and clinical research, supported by a team of scientists, clinicians, and oncology experts.
Founders & leadership
WA

Wahid AwadinCEO & FounderWahid Awad holds a Ph.D. and MBA, with prior experience as Chief Business Officer at CILcare, a biotech and CRO, and founder of a life sciences consulting firm; he is now CEO and founder of Rosetta Omics, which combines spatial multiomics and AI for oncology diagnostics and clinical research.
HA

Hatem AzimChief Medical Officer
MO

Matteo OldaniinChief Financial OfficerMatteo Oldani is a CFO and financial advisor with 18+ years of experience across startups, scale-ups, and large institutions. He holds an ESCP Executive MBA and a CFA Certificate in Sustainability Investing, and currently advises companies on strategy, financial planning, and ESG integration through Frontier Advisory.
NS

Noah SultanChief Data Officer
Investors · 1
Frequently asked questions
- What does Rosetta Omics do?
- Rosetta Omics is a deeptech healthcare startup combining spatial multiomics profiling and AI to advance precision medicine in oncology. It develops technology for cancer diagnostics and clinical research, supported by a team of scientists, clinicians, and oncology experts.
- Who founded Rosetta Omics?
- Rosetta Omics was founded by Wahid Awad.
- Who are Rosetta Omics's investors?
- Rosetta Omics's investors include Agoranov.

